Yanyan Zhu

Yanyan Zhu


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
YZYanyan Zhu
Yanyan Zhu
BCBowang Chen
Bowang Chen
JYJunya Yan
Junya Yan
WZWendi Zhao
Wendi Zhao
PDPengli Dou
Pengli Dou
XHXiaoyun Huang
Xiaoyun Huang
BNIP3 is a BH3-only protein with both pro-apoptotic and pro-survival roles depending on the cellular context. It remains unclear how BNIP3 RNA level dictates cell fate decisions of cancer cells. Here, we undertook a quantitative analysis of BNIP3 expression and functions in single-cell datasets of various epithelial malignancies. Our results demonstrated that BNIP3 upregulation characterizes cancer cell subpopulations with increased fitness and proliferation. We further validated the upregulation of BNIP3 in liver cancer 3D organoid cultures compared with 2D culture. Taken together, the combination of in silico perturbations using public single-cell datasets and experimental cancer modeling using organoids ushered in a new approach to address cancer heterogeneity.

23 March 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
YZYanyan Zhu
Yanyan Zhu
BCBowang Chen
Bowang Chen
JYJunya Yan
Junya Yan
WZWendi Zhao
Wendi Zhao
PDPengli Dou
Pengli Dou
XHXiaoyun Huang
Xiaoyun Huang
BNIP3 is a BH3 only protein with both pro-apoptotic and pro-survival roles depending on the cellular context. It remains unclear how BNIP3 RNA level dictates cell fate decisions of cancer cells. Here we undertook a quantitative analysis of BNIP3 expression and functions in single cell datasets of various epithelial malignancies. Our results demonstrated that BNIP3 upregulation characterizes cancer cell subpopulations with increased fitness and proliferation. We further validated the upregulation of BNIP3 in liver cancer organoids compared with 2D culture. Taken together, the combination of in silico perturbations using public single cell datasets and experimental cancer modeling using organoids ushered in a new approach to address cancer heterogeneity.